Salus Therapeutics

Salt Lake City, UT 84108

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $941K
First Award Date 09/30/99
Most Recent Award Date 08/01/02

Key Personnel

Last Name Name Awards Contact
Ruffner Duane F Ruffner 4
Chen Zhidong Chen 1

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/02 - 07/31/03

Multiple sclerosis (MS) is a debilitating neurodegenerative disease affecting greater than 300,000 Americans. The annual cost of MS. is in excess of 52.5 billion and the cost in terms of human suffering is immeasurable. Current treatments are few, and due to serious side -effects, their use is limited. There exists no cure for MS. Gelatinase-B a...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/01 - 07/31/02

Multiple sclerosis (MS) is a debilitating neurodegenerative disease affecting greater than 300,000 Americans. The annual cost of MS. is in excess of 52.5 billion and the cost in terms of human suffering is immeasurable. Current treatments are few, and due to serious side -effects, their use is limited. There exists no cure for MS. Gelatinase-B a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/10/00 - 03/09/01

DESCRIPTION: (Adapted from the Investigator's Abstract) Cystic fibrosis (CF) is the most common fatal genetic disorder in the United States. Fewer than 50% of CF patients survive to age 31. The disease is characterized by impaired ion transport in epithelial-lined organs, especially the lungs. CF pathology results...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/00 - 03/31/01

Today, 33.4 million people worldwide are living with HIV/AIDS. HIV is the leading cause of death in U.S. adults aged 25-44 years. Despite the effectiveness of current anti-retroviral chemotherapies, treatment failure occurs at rates as high as 20-50% due to drug toxicity and development of drug resistance in the virus. The overall objective of t...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 07/31/01

Multiple sclerosis (MS) is a debilitating neurodegenerative disease affecting greater than 300,000 Americans. The annual cost of MS. is in excess of 52.5 billion and the cost in terms of human suffering is immeasurable. Current treatments are few, and due to serious side -effects, their use is limited. There exists no cure for MS. Gelatinase-B a...